Compare TRIN & BSTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | TRIN | BSTZ |
|---|---|---|
| Founded | 2007 | 2019 |
| Country | United States | United States |
| Employees | 109 | N/A |
| Industry | Finance/Investors Services | Trusts Except Educational Religious and Charitable |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | N/A | N/A |
| Metric | TRIN | BSTZ |
|---|---|---|
| Price | $16.87 | $30.21 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 214.7K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | ★ 12.61% | 8.31% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.71 |
| Revenue | N/A | N/A |
| Revenue This Year | $30.41 | N/A |
| Revenue Next Year | $10.00 | N/A |
| P/E Ratio | ★ $7.18 | $42.70 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.76 | $19.13 |
| 52 Week High | $17.38 | $30.46 |
| Indicator | TRIN | BSTZ |
|---|---|---|
| Relative Strength Index (RSI) | 56.18 | 70.32 |
| Support Level | $14.31 | $21.00 |
| Resistance Level | $17.29 | N/A |
| Average True Range (ATR) | 0.29 | 0.77 |
| MACD | -0.06 | 0.12 |
| Stochastic Oscillator | 55.41 | 90.37 |
Trinity Capital Inc is an internally managed, closed-end, non-diversified management investment company. Its investment objective is to generate current income and, to a lesser extent, capital appreciation through investments across five distinct vertical markets. The company is focused on achieving its investment objective by operating as a specialty lending company that provides debt, including loans, equipment financings, and asset-based lending, to growth-oriented companies, including institutional investor-backed companies. Its investment portfolio mainly comprises private companies that have begun to have success selling their products to the market and need additional capital to expand their operations and sales.
BlackRock Science and Technology Trust II is a non-diversified, closed-end management investment company. The trust's investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. Its portfolio consists of Equity Securities, Options, Preferred Securities, Convertible Securities, Depositary Receipts, Non-U.S. Securities, Emerging Markets Investments, Restricted and Illiquid Investments, Private Company Investments, Corporate Bonds, and other investments. The trust seeks to Invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. science and technology companies in any market capitalization range from the development, advancement, and use of science and/or technology.